Curtis Wright
94Patents
28h-index
21Co-inventors
88Inventor score
Filing activity: Jul 23, 1984 → Oct 12, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6696088B2 | Tamper-resistant oral opioid agonist formulations | Human Necessities | 337 | Expired |
| US7842307B2 | Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent | Human Necessities | 213 | Expired |
| US7141250B2 | Pharmaceutical formulation containing bittering agent | Human Necessities | 209 | Expired |
| US8337888B2 | Pharmaceutical formulation containing gelling agent | Human Necessities | 197 | Active |
| US7144587B2 | Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent | Human Necessities | 194 | Expired |
| US7658939B2 | Tamper-resistant oral opioid agonist formulations | Human Necessities | 165 | Expired |
| US6716449B2 | Controlled-release compositions containing opioid agonist and antagonist | Human Necessities | 159 | Expired |
| US6682757B1 | Titratable dosage transdermal delivery system | Human Necessities | 129 | Expired |
| US8389007B2 | Pharmaceutical composition containing gelling agent | Human Necessities | 95 | Active |
| US8524275B2 | Pharmaceutical formulations containing opioid agonist, opioid antagonist and gelling agent | Human Necessities | 94 | Active |
| US8609683B2 | Pharmaceutical formulation containing gelling agent | Human Necessities | 86 | Active |
| US7790215B2 | Sustained-release gel coated compositions | Human Necessities | 85 | Active |
| US8529948B1 | Pharmaceutical formulation containing gelling agent | Human Necessities | 81 | Active |
| US7384653B2 | Oral dosage form comprising a therapeutic agent and an adverse-effect agent | Human Necessities | 77 | Expired |
| US9060976B2 | Pharmaceutical formulation containing gelling agent | Human Necessities | 76 | Active |
| US7846476B2 | Once-a-day oxycodone formulations | Human Necessities | 64 | Active |
| US9044435B2 | Pharmaceutical formulation containing gelling agent | Human Necessities | 59 | Active |
| US8871265B2 | Pharmaceutical formulation containing gelling agent | Human Necessities | 55 | Active |
| US9034376B2 | Pharmaceutical formulation containing gelling agent | Human Necessities | 50 | Active |
| US7842311B2 | Tamper-resistant oral opioid agonist formulations | Human Necessities | 49 | Expired |
| US8465774B2 | Sequestered antagonist formulations | Human Necessities | 45 | Active |
| US8999961B2 | Pharmaceutical formulation containing gelling agent | Human Necessities | 44 | Active |
| US9040084B2 | Pharmaceutical formulation containing gelling agent | Human Necessities | 42 | Active |
| US7914818B2 | Opioid agonist formulations with releasable and sequestered antagonist | Human Necessities | 40 | Expired |
| US7682632B2 | Tamper-resistant oral opioid agonist formulations | Human Necessities | 36 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.